Review article: the incidence and prevalence of colorectal cancer in inflammatory bowel disease

By P. Munkholm. Alimentary Pharmacology and Therapeutics, 2003

602 citations recorded by the source corpus.

Subfields: Epidemiology, Genetics, Surgery

View Paper: https://www.semanticscholar.org/paper/357b5dc4da7ac62efc12f83cacde37a706bd2e71

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Epidemiology

1. L. Melvin

In Genetics

1. L. Melvin

In Surgery

1. L. Melvin

Citations in the corpus

• Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portuguesa de Endoscopia Digestiva (SPED) (2011, unknown): “grade dysplasia may present as endoscopically visible, depressed, or elevated lesions [34, 201] but may also present as minute or flat lesions that may be isolated or multifocal”
• Effects of estrogen with and without progestin on urinary incontinence (2005, background): “However, colorectal cancer associated with inflammatory bowel diseases accounts for only 1% to 2% of all cases of colorectal cancer in the general population (3).”